GE Healthcare DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand' Premium The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround. RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells. Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board Premium The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports. NeoGenomics Completes Clarient Acquisition The cancer genetics testing provider acquired its new business unit from GE Healthcare. With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu Premium By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab. Oct 21, 2015 NeoGenomics to Acquire Clarient From GE Jul 14, 2015 Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP Dec 4, 2014 Broad Licenses CRISPR/Cas9 IP to GE Healthcare, Sigma-Aldrich Nov 4, 2014 IP Roundup: GE, Luminex, and University of Tokyo Win US Patents Premium Oct 8, 2014 GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas Premium Sep 30, 2014 GE Healthcare's Clarient, GSK Creating Clinical Lab Network to Improve Cancer Dx Sep 25, 2014 IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More Premium Sep 4, 2014 Product Watch: GE Healthcare Illustra Single-Cell DNA Amplification Kit Premium Aug 21, 2014 IP Update: Recent Patents Awarded to Alnylam, Baxter, GE Healthcare, and More Premium Aug 20, 2014 GE Healthcare to Open US Life Sciences HQ in Massachusetts Aug 15, 2014 Fluidigm Refining CyTOF Imaging Platform in Anticipation of 2015 Commercial Release Premium May 8, 2014 Applied Market Watch: GE, NetBio Forensics System; Thermo Fisher Salmonella Assay Premium Mar 24, 2014 GE Finalizes Acquisition of Certain Thermo Fisher Assets Mar 14, 2014 Stanford, Zurich Teams Develop Mass Spec-based Proteomics Technologies for Targeted Tissue Imaging Premium Feb 11, 2014 IP Watch: Life Tech, GE Healthcare, BioMerieux, Qiagen, Others Win US Patents Premium Jan 31, 2014 FTC Says Sale of Certain Thermo Fisher Assets to GE Healthcare is Required for Life Tech Deal OK Jan 30, 2014 Dx Focus: Clarient to Offer BioMerieux's BRAF CDx Premium Jan 6, 2014 GE Buying Thermo Fisher Businesses for $1.06B Dec 13, 2013 GE Studies Demonstrate Use of MultiOmyx Platform for Lymphoma Diagnosis, Breast Cancer Research Premium Oct 23, 2013 People in the News: Jay Flatley, Greg Heath, Justin Johnson, Fei Lu, Biserka Bacic-Toplek, More Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.